Stage-Matched Psychosocial Intervention for Parent Caregivers of Children With Leukemia in Pakistan
SMP-CLP
Development of a Stage Matched Psychosocial Intervention to Enhance Psychological Adaptation Among Parent Caregivers of Children With Leukemia in Pakistan
2 other identifiers
interventional
88
1 country
1
Brief Summary
This study aims to develop, implement, and evaluate a stage-matched psychosocial intervention to enhance the psychological adaptation of parent caregivers of children with leukemia in Pakistan. The intervention is based on the Transactional Family Adaptation Model and Double ABC-X Model of family stress. It will be tailored to meet the specific emotional and behavioral needs of caregivers at different stages of their child's treatment journey. The study consists of four stages: (1) needs assessment, (2) intervention design, (3) intervention refinement, and (4) a pilot randomized controlled trial. The intervention will be tested at two tertiary care hospitals in Pakistan, with an expected sample size of 88 parent caregivers. Outcomes will assess feasibility, acceptability, and preliminary efficacy in improving psychological adaptation, reducing distress, and enhancing coping skills among caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2026
CompletedFirst Submitted
Initial submission to the registry
April 20, 2026
CompletedFirst Posted
Study publicly available on registry
May 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedMay 4, 2026
April 1, 2026
10 months
April 20, 2026
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Psychological Adaptation
The primary outcome measure will assess the psychological adaptation of parent caregivers of children with leukemia. It will be measured using validated scales such as the Psychological Adaptation Scale (PAS), which evaluates the caregiver's emotional response to their child's illness, their coping strategies, and overall psychological adjustment.The scale contains 20 items and 4 dimensions, namely coping ability, self-reliance, social ability and psychological growth. The scale uses the Likert 5-point scoring method, 1 represents strongly disagree and 5 represents strongly agree. The higher the score, the better the psychological adaptation of the caregiver.
Baseline, Mid-Intervention (Week 6), Post-Intervention (Week 12)
Distress
The level of emotional distress (including depression, anxiety, and stress) will be assessed using the DASS-21 (Depression, Anxiety, Stress Scale). The scale will measure the severity of distress experienced by parent caregivers during the intervention period.This scale consists 21 items, with 7 items per for each of the three scales. For reporting the score of the three scales Depression ( Normal 0-9, Mild 5-6, Moderate 7-10, Sever 11-13 and Extremely severe 14+), Anxiety ( Normal 0-3, Mild 4-5, Moderate 6-7, Sever 8-9 and Extremely severe 10+) and Stress ( Normal 0-7, Mild 8-9, Moderate 10-12, Sever 13-16 and Extremely severe 17+).Higher scores on the DASS-21 indicate worse outcomes (i.e., higher levels of distress, including depression, anxiety, and stress).
Baseline, Mid-Intervention (Week 6), Post-Intervention (Week 12)
Caregiver Burden
The Caregiver Burden Scale will be used to assess the burden felt by caregivers in terms of time, physical, emotional, and financial strain due to caregiving responsibilities.It contained 22 items assessing experience of burden. The total score is 88 and for reporting the scale is: No or minimal burden ( 0-20) , Mild to moderate burden (21-40), Moderate to severe burden ( 41-60) and severe burden (61-88). Higher scores on the Caregiver Burden Scale indicate worse outcomes (i.e., higher levels of burden or strain experienced by the caregiver).
Baseline, Mid-Intervention (Week 6), Post-Intervention (Week 12)
Study Arms (2)
Stage-Matched Psychosocial Intervention
EXPERIMENTALParent caregivers in this arm will receive the stage-matched psychosocial intervention in addition to routine medical care over 12 weeks.
Routine Medical Care
NO INTERVENTIONParent caregivers in this arm will receive routine medical care only.
Interventions
This is a culturally adapted, theory-informed psychosocial intervention aimed at improving psychological adaptation and reducing distress among parent caregivers of children with leukemia. The intervention is stage-matched to the caregiver's phase in the child's treatment process and will include psychoeducation, emotional validation, problem-solving skills, and dyadic communication support.
This arm consists of standard medical care provided to caregivers of children diagnosed with leukemia, without any additional psychosocial support intervention. The aim is to compare the outcomes of the intervention group with those receiving routine care.
Eligibility Criteria
You may qualify if:
- Parent caregiver (biological parent, step-parent, or legal guardian) primarily responsible for the daily care of a child diagnosed with leukemia.
- Child is receiving care at one of the participating pediatric oncology study facilities in Pakistan.
- Caregiver is aged 18 years or older.
- Caregiver is able to provide written informed consent.
- Caregiver is willing to participate in the 12-week study and complete study assessments.
- Caregiver is able to communicate in Urdu or another language used for study procedures at the participating site.
You may not qualify if:
- Parent caregiver plans to relocate outside the study area during the study period.
- Parent caregiver is not the primary caregiver of the child with leukemia.
- Parent caregiver is unable to provide informed consent.
- Parent caregiver has a severe cognitive, psychiatric, or medical condition that would prevent participation in the intervention or completion of study assessments, as judged by the study team.
- Parent caregiver is currently participating in another structured psychosocial intervention study that could interfere with this trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hayatabad Medical Complex
Peshawar, Khyber Pakhtunkhwa, 25100, Pakistan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Scholar
Study Record Dates
First Submitted
April 20, 2026
First Posted
May 4, 2026
Study Start
June 10, 2025
Primary Completion
March 30, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) will not be shared due to privacy concerns and the sensitive nature of the data collected in the study. The data involves personal health information, and the confidentiality of participants will be strictly maintained in accordance with ethical and legal requirements. Additionally, due to the study's specific context in pediatric oncology, data sharing is not currently planned